EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut Microbiota as Mediator and Moderator Between Hepatitis B Virus and Hepatocellular Carcinoma: A Prospective Study

Bingren Hu, Yi Yang, Jiangqiao Yao, Ganglian Lin, Qikuan He iD, Zhiyuan Bo, Zhewei Zhang, Anlvna Li, Yi Wang iD, Gang Chen iD, Yunfeng Shan iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.70454 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Bingren Hu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Gastrointestinal Microbiome, Liver Neoplasms, Hepatitis B virus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The impact of gut microbiome on hepatitis B virus (HBV)‐related hepatocellular carcinoma (HCC) is unclear. We aimed to evaluate the potential correlation between gut microbiome and HBV‐related HCC and introduced novel machine learning (ML) signatures based on gut microbe to predict the risk of HCC. Materials and Methods A total of 640 patients with chronic liver diseases or HCC were prospectively recruited between 2019 and 2022. Fecal samples were collected and subjected to 16S rRNA gene sequencing. Univariate and multivariate logistic regression was applied to identify risk characteristics. Several ML methods were employed to construct gut microbe‐based models and the predictive performance was evaluated.

Results

A total of 571 patients were involved in the study, including 374 patients with HCC and 197 patients with chronic liver diseases. After the propensity score matching method, 147 pairs of participants were enrolled in the analysis. Bacteroidia and Bacteroidales were demonstrated to exert mediating effects between HBV and HCC, and the moderating effects varied across Bacilli , Lactobacillales , Erysipelotrichaceae , Actinomyces , and Roseburia . HBV, alpha‐fetoprotein, alanine transaminase, triglyceride, and Child‐Pugh were identified as independent risk factors for HCC occurrence. Seven ML‐based HBV‐gut microbe models were established to predict HCC, with AUCs ranging from 0.821 to 0.898 in the training set and 0.813–0.885 in the validation set. Furthermore, the merged clinical‐HBV‐gut microbe models exhibited a comparable performance to HBV‐gut microbe models.

Conclusions

Gut microbes are important factors between HBV and HCC through its potential mediating and moderating effects, which can be used as valuable biomarkers for the pathogenesis of HBV‐related HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularGastrointestinal MicrobiomeLiver NeoplasmsHepatitis B virusHumansMaleFemaleProspective StudiesMiddle AgedMachine LearningFecesRNA, Ribosomal, 16SRisk FactorsAdultHepatitis BAged

Stichwörter der Autor:innen

gut microbiotagut‐liver axishepatitis B virushepatocellular carcinomamachine learning

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Department of Epidemiology and Biostatistics, School of Public Health, Wenzhou Medical University, Wenzhou, China.
  • The First Clinical College, Wenzhou Medical University, Wenzhou, China.
  • Zhejiang-Germany Interdisciplinary Joint Laboratory of Hepatobiliary-Pancreatic Tumor and Bioengineering, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

ORCID-Profile: Qikuan He, Yi Wang, Gang Chen, Yunfeng Shan

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Hu, B., Yang, Y., Yao, J., Lin, G., He, Q., Bo, Z., Zhang, Z., Li, A., Wang, Y., Chen, G., & Shan, Y. (2024). Gut Microbiota as Mediator and Moderator Between Hepatitis B Virus and Hepatocellular Carcinoma: A Prospective Study. Cancer Medicine. https://doi.org/10.1002/cam4.70454

Vancouver

Hu B, Yang Y, Yao J, Lin G, He Q, Bo Z, et al. Gut Microbiota as Mediator and Moderator Between Hepatitis B Virus and Hepatocellular Carcinoma: A Prospective Study. Cancer Medicine. 2024. doi:10.1002/cam4.70454

BibTeX
@article{Hu2024,
  author = {Hu, Bingren and Yang, Yi and Yao, Jiangqiao and Lin, Ganglian and He, Qikuan and Bo, Zhiyuan and Zhang, Zhewei and Li, Anlvna and Wang, Yi and Chen, Gang and Shan, Yunfeng},
  title = {Gut Microbiota as Mediator and Moderator Between Hepatitis B Virus and Hepatocellular Carcinoma: A Prospective Study},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70454}
}
Kostenlos starten →